Not a Lexis+ subscriber? Try it out for free.


Sanofi-Aventis Settles 3 Lawsuits Over Eloxatin

PARIS – (AP) Sanofi-Aventis has settled three patent infringement lawsuits in the U.S. related to generic versions of colon cancer treatment Eloxatin, the French drug maker said Thursday. Under terms of the settlements, the three generic drug makers Teva Pharmaceuticals USA, Inc., Fresenius Kabi and Sandoz will suspend sales of their products. . . . Full version available to subscribers.